BioLife Solutions, Inc. (BLFS)
After hours:
| Previous close | 23.03 |
| Open | 23.62 |
| Bid | 23.94 x 100 |
| Ask | 24.08 x 100 |
| Day's range | 23.47 - 24.15 |
| 52-week range | 8.92 - 24.15 |
| Volume | |
| Avg. volume | 371,166 |
| Market cap | 1.107B |
| Beta (5Y monthly) | 1.85 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.42 |
| Earnings date | 08 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 25.44 |
Simply Wall St.Is It Time To Consider Buying BioLife Solutions, Inc. (NASDAQ:BLFS)?
BioLife Solutions, Inc. ( NASDAQ:BLFS ), is not the largest company out there, but it saw a significant share price...
PR NewswireBioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's second quarter 2024 financial results will be released after market close on Thursday, August 8, 2024. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general busi
ZacksWhat Makes BioLife Solutions (BLFS) a Good Fit for 'Trend Investing'
BioLife Solutions (BLFS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
